Dermapharm

Grunwald, Germany Founded: 1991 • Age: 35 yrs
Dermatological and pharmaceutical medications are developed and manufactured.
Request Access

About Dermapharm

Dermapharm is a company based in Grunwald (Germany) founded in 1991.. The company has 3,600 employees as of December 31, 2024. Dermapharm has completed 10 acquisitions, including AllergoPharma, Arkopharma and Axicorp. Dermapharm offers products and services including Vitamin D Supplements and Herpes Treatment Device.

  • Headquarter Grunwald, Germany
  • Employees 3600 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Dermapharm Holding Se
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $1.23 B (USD)
    4
    as on Dec 31, 2024
  • Net Profit
    $118.22 M (USD)
    82.44
    as on Dec 31, 2024
  • EBITDA
    $309.47 M (USD)
    -2.31
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    3600

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Dermapharm

Dermapharm is a publicly listed company on the XETR with ticker symbol DMP in Germany, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: XETR · Ticker: DMP . Sector: Health technology · Germany

Products & Services of Dermapharm

Dermapharm offers a comprehensive portfolio of products and services, including Vitamin D Supplements and Herpes Treatment Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Vitamin D supplements are provided for immune system support and individualized dosing in various health applications.

A herpes treatment device is offered for managing lip herpes through warmth application.

Funding Insights of Dermapharm

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Dermapharm

Dermapharm has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include AllergoPharma, Arkopharma and Axicorp. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Nutritional products are provided as a private label brand.
2015
OTC drugs are manufactured by Axicorp in Germany.
2002
Satellite components and launch structures are manufactured for space missions.
1980
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Dermapharm

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dermapharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Dermapharm

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Dermapharm

Frequently Asked Questions about Dermapharm

When was Dermapharm founded?

Dermapharm was founded in 1991.

Where is Dermapharm located?

Dermapharm is headquartered in Grunwald, Germany. It is registered at Grunwald, Bavaria, Germany.

Who is the current CEO of Dermapharm?

Wilhelm Beier is the current CEO of Dermapharm.

How many employees does Dermapharm have?

As of Dec 31, 2024, the latest employee count at Dermapharm is 3,600.

What is the annual revenue of Dermapharm?

Annual revenue of Dermapharm is $1.23B as on Dec 31, 2024.

What does Dermapharm do?

Dermapharm was founded in 1991 and is headquartered in Grunwald, Germany. Operations center on the pharmaceutical sector, with development and production of medications for skin conditions, allergies, and related health issues. The product range encompasses topical dermatological treatments and vitamin supplements. Patient support resources and educational materials are offered to assist users. Focus remains on standard healthcare solutions within the industry.

What products or services does Dermapharm offer?

Dermapharm offers Vitamin D Supplements and Herpes Treatment Device.

Is Dermapharm publicly traded?

Yes, Dermapharm is publicly traded on XETR under the ticker symbol DMP.

How many acquisitions has Dermapharm made?

Dermapharm has made 10 acquisitions, including AllergoPharma, Arkopharma, and Axicorp.

What is Dermapharm's ticker symbol?

The ticker symbol of Dermapharm is DMP on XETR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available